Computational Analysis of Gynura bicolor Bioactive Compounds as Dipeptidyl Peptidase-IV Inhibitor

The inhibition of dipeptidyl peptidase-IV (DPPIV) is a popular route for the treatment of type-2 diabetes. Commercially available gliptin-based drugs such as sitagliptin, anagliptin, linagliptin, saxagliptin, and alogliptin were specifically developed as DPPIV inhibitors for diabetic patients. The u...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozano, Lina, Abdullah Zawawi, Muhammad Redha, Ahmad, Muhamad Aizuddin, Jaganath, Indu Bala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591938/
https://www.ncbi.nlm.nih.gov/pubmed/28932239
http://dx.doi.org/10.1155/2017/5124165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591938/
https://www.ncbi.nlm.nih.gov/pubmed/28932239
http://dx.doi.org/10.1155/2017/5124165

Ejemplares similares